AstraZeneca PLC ADR (AZNN)

1,328.00
0.00(0.00%)
  • Volume:
    892
  • Bid/Ask:
    1,220.27/1,350.00
  • Day's Range:
    1,328.00 - 1,328.00

AZNN Overview

Prev. Close
1,328
Day's Range
1,328-1,328
Revenue
-
Open
1,328
52 wk Range
1,100.02-1,430
EPS
-0.816
Volume
892
Market Cap
4.1T
Dividend (Yield)
1.42
(2.14%)
Average Volume (3m)
939
P/E Ratio
-159.09
Beta
0.119
1-Year Change
11.76%
Shares Outstanding
1,549,489,389
Next Earnings Date
-
What is your sentiment on AstraZeneca ADR?
or
Market is currently closed. Voting is open during market hours.

AstraZeneca PLC ADR News

Welcome to Your News Upgrade

Be the First to Know and Act on Market Moving News.

Welcome to Your News Upgrade
  • FTSE 100 falls to session lows
    • ByProactive Investors-

    FTSE 100 falls in negative territoryChinese retail sales, output numbers below forecastUS markets expected to open lower FTSE 100 slipped to lows for the session ahead of an...

AstraZeneca PLC ADR Analysis

AstraZeneca PLC ADR Company Profile

AstraZeneca PLC ADR Company Profile

Employees
83100
  • Type:Equity
  • Market:Mexico
  • ISIN:US0463531089
  • S/N:046353108

AstraZeneca PLC is a patient-focused pharmaceutical company. The Company focuses on discovery and development, manufacturing and commercialization of prescription medicines. The Company is focused on various therapy areas, such as Oncology; BioPharmaceuticals (comprising Cardiovascular, Renal & Metabolism (CVRM) and Respiratory & Immunology (R&I)), and Rare Disease. Its pipeline forms a robust portfolio of investigational therapies in various stages of clinical development. Its pipeline includes the Alexion Rare Disease portfolio and comprises approximately 177 projects, of which 161 are in the clinical phase of development. Its key marketed oncology products include Tagrisso (osimertinib), Lynparza (olaparib), Imfinzi (durvalumab), Koselugo (selumetinib), Farxiga/ Forxiga (dapagliflozin), Roxadustat, Onglyza (saxagliptin) and others. The Company’s geographical segments include United Kingdom, Rest of Europe, The Americas and Asia, Africa & Australasia.

Read More

Technical Summary

Type
5 Min
15 Min
Hourly
Daily
Monthly
Moving AveragesStrong BuyBuyNeutralNeutralBuy
Technical IndicatorsStrong BuyStrong BuyBuyStrong SellStrong Buy
SummaryStrong BuyStrong BuyNeutralSellStrong Buy
  • Thanks you AstraZ. Bullish. management services.
    0
    • 54 to 64 bullish sentiments again volatility trading
      0
      • $68 in 1 month
        4
        • Do you this will grow as EU has approved their Covid vaccine?
          0
          • will reach 100 in 6 months time
            0
            • I think the vaccine is nothing next to the antibody coctail, known as AZD7442 that Astra is working on at the momenthttps://www.reuters.com/article/health-coronavirus-astrazeneca-antibody-idUSKBN28100E
              0
              • Good buy in the long term.
                1
                • https://www.wsj.com/articles/astrazeneca-agrees-to-buy-alexion-for-39-billion-11607778687?redirect=amp#click=https://t.co/EeYlRyEn3g
                  0
                  • I expect it to reach $ 100 next month
                    1
                    • for super rich returns
                      0